Zoekresultaten - 3 results
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
Verburgh; Marjorie Meurisse; Steven Van Gucht; Veronik Hutse Source: BMC Public Health, Volume 19, Issue 1 (2019) Abstract: BACKGROUND: Prevalence data of chronic hepatitis C virus (HCV) infection are needed ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
recently injected were tested for HCV RNA. CONCLUSIONS: This study supports the need of a continued effort of health care providers to identify people infected with HCV. For a population at risk such as ...
Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method
are adequately maintained. They clearly indicate the need to maximize efforts to achieve the targets set by WHO for 2030 on the provision of 300 sterile needles and syringes per PWID per year, a 90% ...